BUB1B and colorectal cancer: Although scarce, carriers of BUB1B heterozygous deleterious variants have been reported in some cancer patient cohorts, namely, early-onset colorectal cancer [8], familial pancreatic cancer [9], and cutaneous melanoma with multiple primary carcinomas [10].